Biblio

Export 42 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
A. Iyappan, Younesi, E., Redolfi, A., Vrooman, H., Khanna, S., Frisoni, G. B., and Hofmann-Apitius, M., “Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1153-1169, 2017.
A. Iyappan, Gündel, M., Shahid, M., Wang, J., Li, H., Mevissen, H. - T., Müller, B., Fluck, J., Jirsa, V., Domide, L., Younesi, E., and Hofmann-Apitius, M., “Towards a Pathway Inventory of the Human Brain for Modeling Disease Mechanisms Underlying Neurodegeneration.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1343-60, 2016.
N. Iwahara, Hisahara, S., Kawamata, J., Matsumura, A., Yokokawa, K., Saito, T., Fujikura, M., Manabe, T., Suzuki, H., Matsushita, T., Suzuki, S., and Shimohama, S., “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
G. L. Iverson, C Keene, D., Perry, G., and Castellani, R. J., “The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features.”, J Alzheimers Dis, vol. 61, no. 1, pp. 17-28, 2018.
A. V. Ivachtchenko, Okun, I., Aladinskiy, V., Ivanenkov, Y., Koryakova, A., Karapetyan, R., Mitkin, O., Salimov, R., and Ivashchenko, A., “AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1043-1063, 2017.
A. V. Ivachtchenko, Lavrovsky, Y., and Okun, I., “AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.”, J Alzheimers Dis, vol. 53, no. 2, pp. 583-620, 2016.
R. F. Itzhaki, “Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1273-1281, 2016.
N. Ito, Saito, H., Seki, S., Ueda, F., and Asada, T., “Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1767-1775, 2018.
M. Isserles, Daskalakis, Z. J., Kumar, S., Rajji, T. K., and Blumberger, D. M., “Clinical Effectiveness and Tolerability of Electroconvulsive Therapy in Patients with Neuropsychiatric Symptoms of Dementia.”, J Alzheimers Dis, vol. 57, no. 1, pp. 45-51, 2017.
P. Iso-Markku, Waller, K., Vuoksimaa, E., Heikkilä, K., Rinne, J., Kaprio, J., and Kujala, U. M., “Midlife Physical Activity and Cognition Later in Life: A Prospective Twin Study.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1303-1317, 2016.
S. Ismail, Christopher, G., Dodd, E., Wildschut, T., Sedikides, C., Ingram, T. A., Jones, R. W., Noonan, K. A., Tingley, D., and Cheston, R., “Psychological and Mnemonic Benefits of Nostalgia for People with Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1327-1344, 2018.
Z. Ismail, McGirr, A., Gill, S., Hu, S., Forkert, N. D., and Smith, E. E., “Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline.”, J Alzheimers Dis, vol. 80, no. 1, pp. 459-469, 2021.
Z. Ismail, Agüera-Ortiz, L., Brodaty, H., Cieslak, A., Cummings, J., Fischer, C. E., Gauthier, S., Geda, Y. E., Herrmann, N., Kanji, J., Lanctôt, K. L., Miller, D. S., Mortby, M. E., Onyike, C. U., Rosenberg, P. B., Smith, E. E., Smith, G. S., Sultzer, D. L., and Lyketsos, C., “The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.”, J Alzheimers Dis, vol. 56, no. 3, pp. 929-938, 2017.
S. Islamoska, Ishtiak-Ahmed, K., Hansen, Å. Marie, Grynderup, M. Brødsgaar, Mortensen, E. Lykke, Garde, A. Helene, Gyntelberg, F., Prescott, E. Irene Boss, Török, E., Waldemar, G., and Nabe-Nielsen, K., “Vital Exhaustion and Incidence of Dementia: Results from the Copenhagen City Heart Study.”, J Alzheimers Dis, vol. 67, no. 1, pp. 369-379, 2019.
A. G. Isla, Vázquez-Cuevas, F. Gabriel, and Peña-Ortega, F., “Exercise Prevents Amyloid-β-Induced Hippocampal Network Disruption by Inhibiting GSK3β Activation.”, J Alzheimers Dis, vol. 52, no. 1, pp. 333-43, 2016.
A. Ishikawa, Tokunaga, M., Maeda, J., Minamihisamatsu, T., Shimojo, M., Takuwa, H., Ono, M., Ni, R., Hirano, S., Kuwabara, S., Ji, B., Zhang, M. - R., Aoki, I., Suhara, T., Higuchi, M., and Sahara, N., “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1037-1052, 2018.
M. Ishikawa, Yamada, S., and Yamamoto, K., “Dilated Perivascular Spaces in the Centrum Semiovale Begin to Develop in Middle Age.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1619-1626, 2018.
K. Ishii, Yamada, T., Hanaoka, K., Kaida, H., Kojita, Y., Kono, A., Hanada, K., Saigoh, K., Sakuta, S., Hashimoto, M., Kato, T., and Nakamura, A., “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
K. Iqbal, Liu, F., Gong, C. - X., and Grundke-Iqbal, I., “Tau in Alzheimer disease and related tauopathies.”, Curr Alzheimer Res, vol. 7, no. 8, pp. 656-64, 2010.
Y. Inui, Ito, K., and Kato, T., “Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 877-887, 2017.
K. E. Innes, Selfe, T. Kit, Brundage, K., Montgomery, C., Wen, S., Kandati, S., Bowles, H., Khalsa, D. Singh, and Huysmans, Z., “Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial.”, J Alzheimers Dis, vol. 66, no. 3, pp. 947-970, 2018.
K. E. Innes, Selfe, T. Kit, Khalsa, D. Singh, and Kandati, S., “Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 3, pp. 899-916, 2017.
K. E. Innes, Selfe, T. Kit, Khalsa, D. Singh, and Kandati, S., “Effects of Meditation versus Music Listening on Perceived Stress, Mood, Sleep, and Quality of Life in Adults with Early Memory Loss: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1277-98, 2016.
A. P. Ingber, Hassenstab, J., Fagan, A. M., Benzinger, T. L. S., Grant, E. A., Holtzman, D. M., Morris, J. C., and Roe, C. M., “Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1055-64, 2016.

Pages